{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:25:37Z","timestamp":1765545937125},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00520-014-2449-z","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T13:02:34Z","timestamp":1417438954000},"page":"1669-1677","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Mova","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Florendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Marr-Del Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trishala","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"issue":"2011","key":"2449_CR1","first-page":"8","volume":"47","author":"MS Aapro","year":"2010","unstructured":"Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearny N, Lyman GH, Pettengell R et al (2010) Update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disordes and solid tumours. Eur J Cancer 47(2011):8\u201332","journal-title":"Eur J Cancer"},{"issue":"3","key":"2449_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2354.2008.00959.x","volume":"18","author":"D Almenar","year":"2008","unstructured":"Almenar D, Mayans J, Juan O, Bueno JM, Lopez JI, Frau A, Guinot M, Cerezuela P, Buscalla EG, Gasquet JA, Sanchez J (2008) Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain\u2014results of the LEARN Study. Eur J Cancer 18(3):280","journal-title":"Eur J Cancer"},{"key":"2449_CR3","unstructured":"Amgen Manufacturing, Ltd [Internet]. Neulasta Product Monograph. [updated August 18, 2009; cited December 5, 2012]. Available from: http:\/\/www.amgen.ca\/Neulasta.pdf"},{"key":"2449_CR4","unstructured":"Amgen Manufacturing, Ltd [Internet]. Neupogen Product Monograph. [updated August 18, 2009; cited December 5, 2012]. Available from: http:\/\/www.amgen.ca\/Neupogen.pdf"},{"issue":"1","key":"2449_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejon.2008.10.003","volume":"13","author":"J Baker","year":"2009","unstructured":"Baker J, Ajani J, Scotte F, Winther D, Martin M, Aapro MS, von Minckwitz G (2009) Docetaxel-related side effects and their management. Eur J Oncol Nurs 13(1):49\u201359","journal-title":"Eur J Oncol Nurs"},{"issue":"22","key":"2449_CR6","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","volume":"21","author":"HD Bear","year":"2003","unstructured":"Bear HD, Anderson S et al (2003) The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21(22):4165\u20134174","journal-title":"J Clin Oncol"},{"key":"2449_CR7","first-page":"4845","volume":"51","author":"MC Bissery","year":"1991","unstructured":"Bissery MC, Guenard D, Gueritte-Voegelein F et al (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845\u20134852","journal-title":"Cancer Res"},{"issue":"10","key":"2449_CR8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0959-8049(99)00174-4","volume":"35","author":"J Bonneterre","year":"1999","unstructured":"Bonneterre J, Spielman M, Guastalla J-P et al (1999) Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience. Eur J Cancer 35(10):1431\u201339","journal-title":"Eur J Cancer"},{"key":"2449_CR9","unstructured":"Breast Cancer Disease Site Group. Adjuvant taxane therapy for women with early-stage, invasive breast cancer. Madarnas Y, Mates M, Agbassi C, reviewers. Toronto (ON): Cancer Care Ontario; 2011 Sep 30 [Endorsed 2011 Sep 16]. Program in Evidence-based Care Evidence-Based Series No.: 1\u20137 Version 2. Available from: https:\/\/www.cancercare.on.ca\/common\/pages\/UserFile.aspx?fileId=34126 Accessed on 29\/7\/2013"},{"key":"2449_CR10","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.1999.17.8.2341","volume":"17","author":"S Chan","year":"1999","unstructured":"Chan S, Friedrichs K et al (1999) Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17:2341\u20132354","journal-title":"J Clin Oncol"},{"key":"2449_CR11","doi-asserted-by":"crossref","unstructured":"Childs JD, Piva SR, Fritz JM (2005) Responsiveness of the numeric pain rating scale in patients with low back pain. Spine. 30(11):1331\u20131334","DOI":"10.1097\/01.brs.0000164099.92112.29"},{"key":"2449_CR12","unstructured":"e-CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association; c2007 [updated 2006 Feb 27; cited 2008 Jul 30]. Taxotere [product monograph]. Available from: http:\/\/www.e-cps.ca . Also available in paper copy from the publisher"},{"key":"2449_CR13","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http:\/\/globocan.iarc.fr , accessed on 29\/07\/2013"},{"key":"2449_CR14","doi-asserted-by":"crossref","unstructured":"Ferguson T, Wilcken N, Vagg R, Ghersi D, Nowak AK. Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews 2007, Issue 4. [Edited (no change to conclusions) 2010] Art. No.: CD004421. DOI: 10.1002\/14651858.CD004421.pub2","DOI":"10.1002\/14651858.CD004421.pub2"},{"key":"2449_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdg019","volume":"14","author":"MD Green","year":"2003","unstructured":"Green MD, Koelbl H et al (2003) A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol 14:29\u201335","journal-title":"Ann Oncol"},{"issue":"3","key":"2449_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.20.3.727","volume":"20","author":"FA Holmes","year":"2002","unstructured":"Holmes FA, O\u2019Shaughnessy JA et al (2002) Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III\/IV. J Clin Oncol 20(3):727\u201331","journal-title":"J Clin Oncol"},{"key":"2449_CR17","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","volume":"24","author":"SE Jones","year":"2006","unstructured":"Jones SE, Savin MA et al (2006) Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 24:5381\u201387","journal-title":"J Clin Oncol"},{"key":"2449_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1548-5315(11)70107-3","volume":"4","author":"JJ Kirshner","year":"2007","unstructured":"Kirshner JJ, Hickock J et al (2007) Pegfilgrastim-induced bone pain: incidence, risk factors, and management in a community practice. Commun Oncol 4:455\u201359","journal-title":"Commun Oncol"},{"key":"2449_CR19","doi-asserted-by":"crossref","unstructured":"Kotasek D (2011) Febrile neutropenia rates during docetaxel and cyclophosphamide (TC) adjuvant therapy in early breast cancer (EBC). J Clin Oncol; 29 (Suppl; abstr 1101)","DOI":"10.1200\/jco.2011.29.15_suppl.1101"},{"issue":"6","key":"2449_CR20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3816\/CBC.2003.n.003","volume":"3","author":"E Kubista","year":"2003","unstructured":"Kubista E, Glaspy J et al (2003) Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clin Breast Cancer 3(6):391","journal-title":"Clin Breast Cancer"},{"key":"2449_CR21","unstructured":"Myers R, Higgins B, Jeffrey M, et al. Chemotherapy induced febrile neutropenia of docetaxel with cyclophosphamide (TC) for adjuvant therapy of breast cancer in the community: reality check. Poster #2092 presented at: San Antonio Breast Cancer Symposium; December 9\u201313, 2009; San Antonio, TX"},{"issue":"4","key":"2449_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.18553\/jmcp.2007.13.4.337","volume":"13","author":"VA Morrison","year":"2007","unstructured":"Morrison VA, Wong M, Hershman D, Campos LT, Ding B, Malin J (2007) Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3\u20134 week chemotherapy regimens in community oncology practices. J Manag Care Pharm 13(4):337","journal-title":"J Manag Care Pharm"},{"key":"2449_CR23","unstructured":"National Comprehensive Cancer Network [Internet]. Practice Guidelines in Oncology: myeloid growth factors \u2013 v.1.2012. 2012. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/myeloid_growth.pdf . Accessed on 8\/12\/12"},{"key":"2449_CR24","unstructured":"National Comprehensive Cancer Network [Internet]. NCCN Clinical Practice Guidelines in Oncology: breast cancer \u2013 v.3. 2013. Available from http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf . Accessed on 28\/7\/2013"},{"issue":"12","key":"2449_CR25","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2002.09.002","volume":"20","author":"J O\u2019Shaughnessy","year":"2002","unstructured":"O\u2019Shaughnessy J, Miles D, Vukelja S et al (2002) Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 20(12):2812\u201323","journal-title":"J Clin Oncol"},{"issue":"9","key":"2449_CR26","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1185\/030079907X219599","volume":"23","author":"L Pinto","year":"2007","unstructured":"Pinto L, Liu Z et al (2007) Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials. Curr Med Res Opin 23(9):2283","journal-title":"Curr Med Res Opin"},{"key":"2449_CR27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","volume":"59","author":"SN Raja","year":"2002","unstructured":"Raja SN, Haythornthwaite JA et al (2002) Opioids versus antidepressants in post herpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59:1015\u201321","journal-title":"Neurology"},{"key":"2449_CR28","doi-asserted-by":"crossref","unstructured":"Rayson D, Lutes S, et al. Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study. Current Oncology 2012;19 (3)","DOI":"10.3747\/co.19.940"},{"issue":"3","key":"2449_CR29","first-page":"175","volume":"23","author":"W Renwick","year":"2009","unstructured":"Renwick W, Pettengell R et al (2009) Use of filgrastim and pegfilgrastim to support delivery of chemotherapy. Bio drugs 23(3):175","journal-title":"Bio drugs"},{"issue":"36","key":"2449_CR30","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1200\/JCO.2006.07.3916","volume":"24","author":"H Roch\u00e9","year":"2006","unstructured":"Roch\u00e9 H, Fumoleau P, Spielmann M et al (2006) Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. J Clin Oncol 24(36):5664\u201371","journal-title":"J Clin Oncol"},{"key":"2449_CR31","doi-asserted-by":"crossref","unstructured":"Sierra J, Harms R, Mo M, Vogel CL (2009) Evaluation of reported bone pain in patients receiving chemotherapy in pegfilgrastim clinical trials. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition).; 27 (15S): 9621","DOI":"10.1200\/jco.2009.27.15_suppl.9621"},{"issue":"2","key":"2449_CR32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3747\/co.v17i2.498","volume":"17","author":"T Vandenberg","year":"2010","unstructured":"Vandenberg T, Younus J, Al-Khayyat S (2010) Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice\u2014a retrospective analysis. Curr Oncol 17(2):2\u20133","journal-title":"Curr Oncol"},{"issue":"3","key":"2449_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/COC.0b013e31820dc075","volume":"35","author":"D Weycker","year":"2012","unstructured":"Weycker D, Malin J, Barron R, Edelsberg J, Kartashov A, Oster G (2012) Comparative effectiveness of filgrastim, pegfilgrastim and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol 35(3):267\u2013274","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"2449_CR34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.clinthera.2009.05.019","volume":"31","author":"D Weycker","year":"2009","unstructured":"Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G (2009) Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther 31(5):1069","journal-title":"Clin Ther"},{"key":"2449_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/cc1521","volume":"6","author":"E Whitley","year":"2002","unstructured":"Whitley E, Ball J (2002) Statistics review 4: sample size calculations. Crit Care 6:335\u201341","journal-title":"Crit Care"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2449-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2449-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2449-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T15:40:19Z","timestamp":1650728419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2449-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2449"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2449-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]}}}